drugset / Trial / NCT01205269
The Study Will Evaluate the Effect of AZD8683 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to investigate effects of inhaled AZD8683 compared to placebo in COPD patients.
Timeline
- Start
- 2010-10
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD8683 | Unknown | 50 ug | Inhaled |
| Subject | AZD8683 | Unknown | 200 ug | Inhaled |